Skip to content

Exercise and amino acid combined therapy in patients with cardiovascular disease

Exercise and amino acid combined therapy in patients with cardiovascular disease - Ex-Amino study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000037732
Enrollment
90
Registered
2019-08-20
Start date
2019-08-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients with cardiovascular disease

Interventions

Patients in the amino acid preparation group take 5000mg of amino acid adding on exercise therapy during 150 days. Patients in non-amino acid group take only exercise therapy during 150 days.

Sponsors

Gunma Prefectural Cardiovascular Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The outpatients who have been diagnosed with cardiovascular disease and are enrolled cardiac rehabilitation program.

Exclusion criteria

Exclusion criteria: 1.Patients whose doctors banned amino acid preparations 2.Patients whose doctor decided to cancel during the study 3.Patients who have difficulty in continuing to participate in cardiac rehabilitation 4.Patients who have had no more than 2 cancels in cardiac rehabilitation 5.Patients who have difficulty participating in outpatient rehabilitation more than twice a week 6.Patients with dysphagia who have difficulty taking amino acid preparations 7.Patients who have not given consent to participate in the study

Design outcomes

Primary

MeasureTime frame
Peak VO2

Countries

Japan

Contacts

Public ContactHarue Nakano

Gunma Prefectural Cardiovascular Center Rehabilitation Division

nakano-h@cvc.pref.gunma.jp027-269-7455

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026